title: Venlafaxine: a novel antidepressant.
abstract: More and more antidepressants are being used to treat depression that do not meet DSM-IV criteria for major depression. Venlafaxine is one alternative among many pharmacologic agents. Studies suggest it provides as good a response as other antidepressants, is less cardiotoxic, and produces fewer anticholinergic and sedative side effects.
authors.affiliation: Graduate Programs, School of Nursing, University of Alabama at Birmingham 35294, USA.
authors.forename: N L
authors.initials: NL
authors.lastname: Keltner
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D017028:Caregivers / Q000523:psychology; D003511:Cyclohexanols / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008875:Middle Aged; D013315:Stress, Psychological / Q000150:complications; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride